US Stock MarketDetailed Quotes

Amphastar Pharmaceuticals (AMPH)

Watchlist
  • 20.370
  • -0.500-2.40%
Close Apr 10 15:59 ET
  • 20.370
  • 0.0000.00%
Post 20:01 ET
924.19MMarket Cap10.03P/E (TTM)

Amphastar Pharmaceuticals (AMPH) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-26.84%156.12M
13.23%32.86M
-12.31%52.58M
-48.50%35.59M
-36.56%35.08M
16.28%213.39M
21.62%29.02M
-6.80%59.96M
25.83%69.11M
36.92%55.29M
Net income from continuing operations
-38.51%98.09M
-35.65%24.43M
-57.09%17.35M
-18.23%31.03M
-41.44%25.29M
15.98%159.52M
4.97%37.96M
-17.86%40.43M
45.26%37.95M
65.86%43.18M
Operating gains losses
214.52%2.53M
110.87%477K
-95.30%286K
-329.27%-376K
152.65%2.14M
-128.38%-2.21M
-164.03%-4.39M
334.48%6.09M
-93.56%164K
-514.66%-4.07M
Depreciation and amortization
10.48%63.2M
9.02%15.99M
9.25%15.77M
14.80%16.24M
8.91%15.21M
36.93%57.21M
6.35%14.66M
6.35%14.43M
101.47%14.15M
88.79%13.96M
Deferred tax
262.70%27.63M
----
----
----
----
-23.62%-16.98M
----
----
----
----
Other non cash items
-44.38%3.36M
19.61%866K
18.95%885K
-65.44%842K
-64.19%762K
-47.08%6.03M
-75.15%724K
-85.79%744K
-23.64%2.44M
3,506.78%2.13M
Change In working capital
-353.50%-65.97M
-397.43%-42.73M
263.74%12M
-314.53%-18.53M
-130.06%-16.71M
39.91%-14.55M
67.88%-8.59M
-27.56%-7.33M
1.85%8.64M
-3,569.19%-7.27M
-Change in receivables
70.62%-6.37M
11.22%3.23M
-71.21%-13.79M
83.67%12.27M
65.20%-8.08M
16.92%-21.67M
-28.93%2.91M
58.99%-8.06M
428.82%6.68M
-96.69%-23.2M
-Change in inventory
56.84%-21.06M
136.82%9.01M
180.18%5.86M
31.37%-4.82M
-211.27%-31.11M
-2,730.45%-48.8M
-608.37%-24.47M
-26.67%-7.31M
-578.74%-7.03M
-3,829.48%-10M
-Change in prepaid assets
67.09%-3.53M
4,246.84%9.83M
25.99%-7.94M
-1,154.97%-4.57M
-342.19%-849K
-293.18%-10.73M
91.63%-237K
-1,589.76%-10.73M
-16.89%433K
-187.67%-192K
-Change in payables and accrued expense
-107.17%-4.56M
-2,119.13%-42.64M
2.80%25.34M
-135.40%-4.86M
-23.72%17.61M
380.19%63.56M
162.34%2.11M
208.02%24.65M
341.46%13.73M
318.53%23.08M
-Change in other current liabilities
-49.57%-5.61M
-87.33%-1.66M
-64.36%-1.59M
-69.09%-1.61M
20.38%-754K
-4.49%-3.75M
4.12%-884K
-5.56%-968K
-7.09%-951K
-9.86%-947K
-Change in other working capital
-463.52%-24.84M
-271.09%-20.5M
183.90%4.12M
-253.45%-14.94M
62.07%6.47M
305.91%6.83M
142.03%11.98M
-137.17%-4.91M
-176.72%-4.23M
-38.19%3.99M
Cash from discontinued investing activities
Operating cash flow
-26.84%156.12M
13.23%32.86M
-12.31%52.58M
-48.50%35.59M
-36.56%35.08M
16.28%213.39M
21.62%29.02M
-6.80%59.96M
25.83%69.11M
36.92%55.29M
Investing cash flow
Cash flow from continuing investing activities
43.70%-70.33M
-69.77%-60.57M
43.27%-19.62M
99.11%-625K
-31.21%10.48M
80.75%-124.93M
65.38%-35.68M
-11.02%-34.59M
86.26%-69.9M
340.60%15.24M
Net PPE purchase and sale
15.01%-34.88M
33.35%-8.27M
61.23%-5.35M
-74.80%-10.57M
-21.65%-10.7M
-7.53%-41.04M
-31.44%-12.41M
-35.32%-13.79M
33.24%-6.04M
7.22%-8.79M
Net intangibles purchase and sale
---2.25M
--0
--0
----
----
--0
--0
--0
----
----
Net business purchase and sale
--0
--0
--0
----
----
74.53%-129M
--0
--0
----
----
Net investment purchase and sale
-158.58%-28.84M
-137.89%-51.86M
35.76%-12.68M
-78.24%14.53M
-11.87%21.18M
146.47%49.23M
76.29%-21.8M
-1.85%-19.74M
2,888.67%66.74M
664.31%24.03M
Net other investing changes
-5.88%-4.36M
70.40%-434K
-50.61%-1.59M
----
----
-396.33%-4.12M
12.43%-1.47M
-126.45%-1.06M
----
----
Cash from discontinued investing activities
Investing cash flow
43.70%-70.33M
-69.77%-60.57M
43.27%-19.62M
99.11%-625K
-31.21%10.48M
80.75%-124.93M
65.38%-35.68M
-11.02%-34.59M
86.26%-69.9M
340.60%15.24M
Financing cash flow
Cash flow from continuing financing activities
16.71%-67.43M
45.71%-18.37M
80.95%-4.35M
-181.84%-30.2M
-6.80%-14.5M
-117.83%-80.95M
28.12%-33.84M
-126.34%-22.82M
-102.50%-10.72M
-0.23%-13.58M
Net issuance payments of debt
-41.07%5.99M
-96.44%169K
-98.65%128K
150.93%4.09M
-59.74%1.6M
-98.07%10.17M
109.48%4.75M
-93.47%9.47M
-101.86%-8.03M
511.57%3.98M
Net common stock issuance
11.55%-75.59M
51.15%-20.52M
86.13%-4.85M
-361.52%-39.22M
---11M
-46.98%-85.46M
---42M
30.09%-34.96M
-6,539.06%-8.5M
--0
Proceeds from stock option exercised by employees
158.88%2.86M
-41.45%1.98M
-88.38%379K
-10.94%5.18M
72.94%-4.69M
-144.19%-4.85M
-4.92%3.39M
53.43%3.26M
-40.98%5.82M
-279.21%-17.31M
Net other financing activities
15.81%-687K
-136.36%-8K
99.32%-4K
-25,400.00%-253K
-67.46%-422K
96.75%-816K
104.48%22K
94.38%-587K
--1K
---252K
Cash from discontinued financing activities
Financing cash flow
16.71%-67.43M
45.71%-18.37M
80.95%-4.35M
-181.84%-30.2M
-6.80%-14.5M
-117.83%-80.95M
28.12%-33.84M
-126.34%-22.82M
-102.50%-10.72M
-0.23%-13.58M
Net cash flow
Beginning cash position
5.06%151.84M
12.55%216.5M
-1.02%187.92M
-9.12%183.02M
5.06%151.84M
-7.55%144.53M
-29.03%192.35M
25.50%189.85M
13.87%201.38M
-7.55%144.53M
Current changes in cash
144.68%18.36M
-13.79%-46.08M
1,017.85%28.62M
141.40%4.77M
-45.47%31.06M
165.13%7.5M
67.93%-40.5M
-97.86%2.56M
54.95%-11.51M
177.79%56.95M
Effect of exchange rate changes
210.53%210K
18.18%-9K
34.92%-41K
847.37%142K
221.65%118K
32.62%-190K
95.38%-11K
-65.79%-63K
13.64%-19K
-706.25%-97K
End cash Position
12.23%170.41M
12.23%170.41M
12.55%216.5M
-1.02%187.92M
-9.12%183.02M
5.06%151.84M
5.06%151.84M
-29.03%192.35M
25.50%189.85M
13.87%201.38M
Free cash flow
-30.96%118.98M
48.02%24.59M
2.31%47.24M
-63.88%22.78M
-47.57%24.38M
18.58%172.35M
15.19%16.61M
-14.72%46.17M
37.49%63.07M
50.45%46.5M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -26.84%156.12M13.23%32.86M-12.31%52.58M-48.50%35.59M-36.56%35.08M16.28%213.39M21.62%29.02M-6.80%59.96M25.83%69.11M36.92%55.29M
Net income from continuing operations -38.51%98.09M-35.65%24.43M-57.09%17.35M-18.23%31.03M-41.44%25.29M15.98%159.52M4.97%37.96M-17.86%40.43M45.26%37.95M65.86%43.18M
Operating gains losses 214.52%2.53M110.87%477K-95.30%286K-329.27%-376K152.65%2.14M-128.38%-2.21M-164.03%-4.39M334.48%6.09M-93.56%164K-514.66%-4.07M
Depreciation and amortization 10.48%63.2M9.02%15.99M9.25%15.77M14.80%16.24M8.91%15.21M36.93%57.21M6.35%14.66M6.35%14.43M101.47%14.15M88.79%13.96M
Deferred tax 262.70%27.63M-----------------23.62%-16.98M----------------
Other non cash items -44.38%3.36M19.61%866K18.95%885K-65.44%842K-64.19%762K-47.08%6.03M-75.15%724K-85.79%744K-23.64%2.44M3,506.78%2.13M
Change In working capital -353.50%-65.97M-397.43%-42.73M263.74%12M-314.53%-18.53M-130.06%-16.71M39.91%-14.55M67.88%-8.59M-27.56%-7.33M1.85%8.64M-3,569.19%-7.27M
-Change in receivables 70.62%-6.37M11.22%3.23M-71.21%-13.79M83.67%12.27M65.20%-8.08M16.92%-21.67M-28.93%2.91M58.99%-8.06M428.82%6.68M-96.69%-23.2M
-Change in inventory 56.84%-21.06M136.82%9.01M180.18%5.86M31.37%-4.82M-211.27%-31.11M-2,730.45%-48.8M-608.37%-24.47M-26.67%-7.31M-578.74%-7.03M-3,829.48%-10M
-Change in prepaid assets 67.09%-3.53M4,246.84%9.83M25.99%-7.94M-1,154.97%-4.57M-342.19%-849K-293.18%-10.73M91.63%-237K-1,589.76%-10.73M-16.89%433K-187.67%-192K
-Change in payables and accrued expense -107.17%-4.56M-2,119.13%-42.64M2.80%25.34M-135.40%-4.86M-23.72%17.61M380.19%63.56M162.34%2.11M208.02%24.65M341.46%13.73M318.53%23.08M
-Change in other current liabilities -49.57%-5.61M-87.33%-1.66M-64.36%-1.59M-69.09%-1.61M20.38%-754K-4.49%-3.75M4.12%-884K-5.56%-968K-7.09%-951K-9.86%-947K
-Change in other working capital -463.52%-24.84M-271.09%-20.5M183.90%4.12M-253.45%-14.94M62.07%6.47M305.91%6.83M142.03%11.98M-137.17%-4.91M-176.72%-4.23M-38.19%3.99M
Cash from discontinued investing activities
Operating cash flow -26.84%156.12M13.23%32.86M-12.31%52.58M-48.50%35.59M-36.56%35.08M16.28%213.39M21.62%29.02M-6.80%59.96M25.83%69.11M36.92%55.29M
Investing cash flow
Cash flow from continuing investing activities 43.70%-70.33M-69.77%-60.57M43.27%-19.62M99.11%-625K-31.21%10.48M80.75%-124.93M65.38%-35.68M-11.02%-34.59M86.26%-69.9M340.60%15.24M
Net PPE purchase and sale 15.01%-34.88M33.35%-8.27M61.23%-5.35M-74.80%-10.57M-21.65%-10.7M-7.53%-41.04M-31.44%-12.41M-35.32%-13.79M33.24%-6.04M7.22%-8.79M
Net intangibles purchase and sale ---2.25M--0--0----------0--0--0--------
Net business purchase and sale --0--0--0--------74.53%-129M--0--0--------
Net investment purchase and sale -158.58%-28.84M-137.89%-51.86M35.76%-12.68M-78.24%14.53M-11.87%21.18M146.47%49.23M76.29%-21.8M-1.85%-19.74M2,888.67%66.74M664.31%24.03M
Net other investing changes -5.88%-4.36M70.40%-434K-50.61%-1.59M---------396.33%-4.12M12.43%-1.47M-126.45%-1.06M--------
Cash from discontinued investing activities
Investing cash flow 43.70%-70.33M-69.77%-60.57M43.27%-19.62M99.11%-625K-31.21%10.48M80.75%-124.93M65.38%-35.68M-11.02%-34.59M86.26%-69.9M340.60%15.24M
Financing cash flow
Cash flow from continuing financing activities 16.71%-67.43M45.71%-18.37M80.95%-4.35M-181.84%-30.2M-6.80%-14.5M-117.83%-80.95M28.12%-33.84M-126.34%-22.82M-102.50%-10.72M-0.23%-13.58M
Net issuance payments of debt -41.07%5.99M-96.44%169K-98.65%128K150.93%4.09M-59.74%1.6M-98.07%10.17M109.48%4.75M-93.47%9.47M-101.86%-8.03M511.57%3.98M
Net common stock issuance 11.55%-75.59M51.15%-20.52M86.13%-4.85M-361.52%-39.22M---11M-46.98%-85.46M---42M30.09%-34.96M-6,539.06%-8.5M--0
Proceeds from stock option exercised by employees 158.88%2.86M-41.45%1.98M-88.38%379K-10.94%5.18M72.94%-4.69M-144.19%-4.85M-4.92%3.39M53.43%3.26M-40.98%5.82M-279.21%-17.31M
Net other financing activities 15.81%-687K-136.36%-8K99.32%-4K-25,400.00%-253K-67.46%-422K96.75%-816K104.48%22K94.38%-587K--1K---252K
Cash from discontinued financing activities
Financing cash flow 16.71%-67.43M45.71%-18.37M80.95%-4.35M-181.84%-30.2M-6.80%-14.5M-117.83%-80.95M28.12%-33.84M-126.34%-22.82M-102.50%-10.72M-0.23%-13.58M
Net cash flow
Beginning cash position 5.06%151.84M12.55%216.5M-1.02%187.92M-9.12%183.02M5.06%151.84M-7.55%144.53M-29.03%192.35M25.50%189.85M13.87%201.38M-7.55%144.53M
Current changes in cash 144.68%18.36M-13.79%-46.08M1,017.85%28.62M141.40%4.77M-45.47%31.06M165.13%7.5M67.93%-40.5M-97.86%2.56M54.95%-11.51M177.79%56.95M
Effect of exchange rate changes 210.53%210K18.18%-9K34.92%-41K847.37%142K221.65%118K32.62%-190K95.38%-11K-65.79%-63K13.64%-19K-706.25%-97K
End cash Position 12.23%170.41M12.23%170.41M12.55%216.5M-1.02%187.92M-9.12%183.02M5.06%151.84M5.06%151.84M-29.03%192.35M25.50%189.85M13.87%201.38M
Free cash flow -30.96%118.98M48.02%24.59M2.31%47.24M-63.88%22.78M-47.57%24.38M18.58%172.35M15.19%16.61M-14.72%46.17M37.49%63.07M50.45%46.5M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On the morning of the 11th local time, Pakistani officials confirmed that delegations from the United States and Iran will hold negotiations Show More